Daohong Zhou

Daohong Zhou, M.D.

Professor And The Henry E. Innes Professorship Of Cancer Research

Department: Pharmacodynamics
Business Phone: (352) 294-8952
Business Email: zhoudaohong@cop.ufl.edu

About Daohong Zhou

Dr. Daohong Zhou is a Professor in the Department of Pharmacodynamics at the College of Pharmacy and a Professor in the Department of Radiation Oncology at the College of Medicine, University of Florida (UF) at Gainesville. He serves as the Associate Director for Translation and Drug Development and the Henry E. Innes Professorsip of Cancer Research at the UF Health Cancer Center. Dr. Zhou received his medical (1978-1983) and graduate (1983-1986) training from Yunyany Medical College of Tongji Medical University and Henan Medical University, respectively; and his postdoctoral training (1990-1992) at the Johns Hopkins University School of Medicine. Before he joined UF in 2018, he was a Professor of Pharmaceutical Sciences and the Deputy Director of the Division of Radiation Health at the College of Pharmacy and the Associate Director for Basic Research at the Winthrop P. Rockefeller Cancer Institute in the University of Arkansas for Medical Sciences (UAMS).

Dr. Daohong Zhou has published more than 100 peer reviewed scientific articles and book chapters. His research has been well supported by grants from various private and government funding agencies, including the National Cancer Institute (NCI) and National Institute of Allergy and Infectious Disease (NIAID). Dr. Daohong Zhou serves on several national and international peer review panels and as a reviewer for various scientific publications. He was a regular member of the Radiation Therapeutics and Biology Study Section at the National Institutes of Health (NIH) and a co-chair of the Panel Meeting for General Program of the Dept. of Health Sciences (Hematology) at the National Natural Science Foundation of China (NSFC). He is a Councilor of the Radiation Research Society (http://www.radres.org) and a co-founder of Unity Biotechnology (http://unitybiotechnology.com), a biotech that develops senolytic drugs for aging and age-related diseases.

Honors & Awards

Henry E. Innes Professorsip of Cancer Research
2018-Current · University of Florida
Established Investigator of Year Award
2016 · The Arkansas Biosciences Institute
The Winthrop Rockefeller Endowed Chair for Leukemia and Lymphoma Research
2010-2018 · University of Arkansas for Medical Sciences
Scholar
2010-2018 · Arkansas Research Alliance

Grants

Sep 2019 ACTIVE
Use of BCL-xL Proteolysis targeting chimeras to treat pancreatic cancer
NATL INST OF HLTH NCI · Principal Investigator
Aug 2019 ACTIVE
Develop BCL-xL proteolysis targeting chimeras as safer and better senolytics
NATL INST OF HLTH NIA · Principal Investigator
Sep 2018 – Feb 2020
Cancer Therapy-induced Long-term Bone Marrow Injury
NATL INST OF HLTH NCI · Principal Investigator
Sep 2018 ACTIVE
NCI Clinical and Translational Exploratory/ Developmental Studies
NATL INST OF HLTH NCI ·
Aug 2018 – Aug 2019
Discovery and Target Identification of Senolytic Agents
NATL INST OF HLTH NIA ·
Jul 2018 ACTIVE
Role of Senescent Cells in Radiation-induced Pulmonary Fibrosis
NATL INST OF HLTH NCI · Principal Investigator
Jun 2018 – May 2019
The 4th International Cell Senescence Association (ICSA) meeting (ICSA 2018) Resubmission
NATL INST OF HLTH NIA · Principal Investigator
Apr 2018 ACTIVE
Ionizing radiation induced hematological malignancies
NATL INST OF HLTH NCI · Principal Investigator

Education

M.S.
1986 · Henan Medical University
M.D.
1982 · Yunyang Medical College

Contact Details

Phones:
Business:
(352) 294-8952
Emails: